Field | Before | After |
---|---|---|
Field Trial Status | Before in_development | After completed |
Field Trial End Date | Before November 30, 2021 | After March 14, 2019 |
Field Last Published | Before April 04, 2017 11:33 AM | After March 15, 2019 02:21 PM |
Field Study Withdrawn | Before | After No |
Field Intervention Completion Date | Before | After December 15, 2017 |
Field Data Collection Complete | Before | After Yes |
Field Was attrition correlated with treatment status? | Before | After No |
Field Final Sample Size: Total Number of Observations | Before | After 3,511 |
Field Final Sample Size (or Number of Clusters) by Treatment Arms | Before | After 1,756 health care providers control, 1,755 health care providers |
Field Public Data URL | Before | After https://doi.org/10.7910/DVN/BRKDVQ |
Field Is there a restricted access data set available on request? | Before | After No |
Field Program Files | Before | After Yes |
Field Program Files URL | Before | After https://doi.org/10.7910/DVN/BRKDVQ |
Field Data Collection Completion Date | Before | After March 15, 2018 |
Field Is data available for public use? | Before | After Yes |
Field | Before | After |
---|---|---|
Field Paper Abstract | Before | After There is widespread concern over the health risks and healthcare costs from potentially inappropriate high-cost imaging. As a result, the Centers for Medicare and Medicaid Services (CMS) will soon require high-cost imaging orders to be accompanied by Clinical Decision Support (CDS): software that provides appropriateness information at the time orders are placed via a best practice alert for targeted (i.e. likely inappropriate) imaging orders, although the impacts of CDS in this context are unclear. In this randomized trial of 3,511 healthcare providers at Aurora Health Care, we study the impacts of CDS on the ordering behavior of providers. We find that CDS reduced targeted imaging orders by a statistically significant 6%, however there was no statistically significant change in the total number of high-cost scans or of low-cost scans. The results suggest that the impending CMS mandate requiring healthcare systems to adopt CDS may modestly increase the appropriateness of high-cost imaging. |
Field Paper Citation | Before | After Doyle J, Abraham S, Feeney L, Reimer S, Finkelstein A (2019) Clinical decision support for high-cost imaging: A randomized clinical trial. PLoS ONE 14(3): e0213373. https://doi.org/10.1371/journal.pone.0213373 |
Field Paper URL | Before | After https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0213373 |